Skip to content

Owlet OWLT Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
Silicon Laboratories logo
Silicon LaboratoriesSLAB
iRadimed logo
iRadimedIRMD
Health Catalyst logo
Health CatalystHCAT
Intuitive Surgical logo
Intuitive SurgicalISRG

Other financials

Income statement

See full
Revenue$22.5M+6.4%
Gross profit$12.2M+8.1%
Operating income-$5.5M-106%
Net income-$3.3M-210%
EPS (diluted)-$0.25-327%

Balance sheet

See full
Cash & equivalents$41.0M+147%
Total debt$35.6M+48.6%
Total equity$21.0M+181%
Total assets$86.8M+68.8%

Cash flow

See full
Operating cash flow-$5.0M+14.8%
CapEx$15.0K+275%
Free cash flow-$5.1M+14.6%

Valuation

See full
Market cap$166.47M+30.3%
Enterprise value$161.04M+12.4%
P/S1.6×+0.1×

Profitability

See full
Gross margin50.9%-1.4pp
Operating margin-10.4%-3.4pp
Net margin-43%-94.2pp
FCF margin-9.5%

Returns & leverage

See full
Return on equity-206.1%
Debt / equity1.7×
Current ratio1.7×+0.5×

Where this comes from

Reported directly by Owlet in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Owlet’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Owlet's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Owlet's common stock, shares authorized (in shares)?
Owlet (OWLT) reported common stock, shares authorized (in shares) of $107.14M in Q1 2026.
How has Owlet's common stock, shares authorized (in shares) changed year-over-year?
Owlet's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $107.14M to $107.14M.
What is the long-term trend for Owlet's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Owlet's common stock, shares authorized (in shares) has grown at a -42.8% compound annual growth rate (CAGR), from $1B to $107.14M.